Patients who achieve at least 5% body weight loss after 12 weeks at the full 3.0mg dose are typically continued on treatment as part of a chronic weight management plan
Secondary endpoints in CVOTs with GLP-1 RAs have also suggested potential kidney benefits, primarily through reductions in albuminuria, with some trials reporting a mitigation of eGFR decline [16,17,18,19, 56, 57]
00:00:00 In this section, the speaker discusses his updated perspective on certain longevity supplements, specifically tocotrienols (toine), NAD+ boosters like nasin, and vitamin D customization, drawing from recent studies showing their impact on aging defense
It means dealing with global economies, considering that 90% of world trade passes through the sea
NAD+ directly relevant to the methyl/nicotinamide axis modulated by NNMT inhibition